NEOP was just given a price target of $6 within the last couple of days, and we seem to have a number of events on the horizon, plus institutional visibility due to the AMEX listing we just got. I think one should do very well in 2011 and all things associated with oncology are always interesting to the market. So we shall see but I think it has a bright future. jmho Course a profit is the objective for us so you obviously accomplish that, KUDOS
George and Ike - wonder if George is getting chewed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.